Trademark: 79281569
Word
BACHEM
Status
Registered
Status Code
700
Status Date
Tuesday, June 7, 2022
Serial Number
79281569
Registration Number
6748998
Registration Date
Tuesday, June 7, 2022
Mark Type
4000
Filing Date
Friday, December 27, 2019
Published for Opposition
Tuesday, February 15, 2022

Trademark Owner History
Bachem Holding AG - Original Registrant

Classifications
40 Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacturing of peptides; custom manufacturing of proteins; custom manufacturing of oligonucleotides; processing of chemicals; processing of chemical reagents; processing of peptides; processing of proteins; processing of oligonucleotides; processing of medicinal materials; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials
5 Chemical reagents for medical or veterinary use; reagents for medical use; peptides for medical use; protein arrays for medical diagnostic use; oligonucleotides for medical use; amino acids for medical use; peptides for pharmaceutical use; synthetic peptides for pharmaceutical use; peptides for veterinary use; amino acids for veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological and pharmaceutical preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary use; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; chemical preparations for the diagnosis of pregnancy; biological and chemical reagents for medical or veterinary use; biological preparations for diagnostic purposes; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations for wound healing; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against neurological diseases; biological reagents for medical use; biological reagents for veterinary use; adjuvants for medical use; adjuvants for veterinary use; anti-bacterial preparations for medical purposes; anti-cancer preparations; antitumor drugs; biopharmaceutical anti-tumor medicines; biopharmaceuticals for the treatment of cancer; anti-diabetic preparations; chemotherapeutics; cosmeceuticals for therapeutic or medical use, namely, medicated soap; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic preparations adapted for medical use; dietetic preparations adapted for veterinary use; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing
1 Chemicals for use in industry and science; chemical preparations for scientific use; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific use; chemical preparations for scientific use, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; chemicals for industry; chemical reagents for scientific use; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; oligopeptides for industrial use; proteins for industrial use; proteins for use in manufacture; amino acids for industrial use; amino acids for scientific use; peptide substrates for scientific use; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; chemical preparations for use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; chemical reagents for use in genetic research; chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of anti-diabetes drugs; active chemical ingredients for use in the manufacture of drugs against metabolic diseases; active chemical ingredients for use in the manufacture of drugs for wound healing; active chemical ingredients for use in the manufacture of drugs against genetic diseases; active chemical ingredients for use in the manufacture of drugs against neurological diseases; amides for use in manufacture; chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research use; diagnostic preparations, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical or veterinary use; biological preparations for use in industry and science; biological preparations, other than for medical or veterinary use; adjuvants, other than for medical or veterinary purposes; biochemical catalysts; biochemical preparations for scientific use; biochemicals for in vitro and in vivo scientific use; emollients for industrial use; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceuticals; enzyme stabilizers; enzyme substrates; phosphoproteins
42 Scientific research; chemical research; chemical engineering; product research and development; research and development of new products for others; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of methods of manufacture for peptides, proteins, oligonucleotides, pharmaceuticals, and cosmetics; development of analytic methods for developing for peptides, proteins, oligonucleotides, pharmaceuticals, and cosmetics; scientific laboratory services; chemical analysis; chemical, biochemical, biological and bacteriological research and analysis; analysis in the form of research in the field of molecular biology; conducting of scientific feasibility studies; providing information in the form of preparation of reports relating to scientific research; quality control; product testing; advisory services relating to material testing; consultancy in the field of biochemistry research; consultancy in the field of chemistry research; consultancy in the field of scientific and industrial research; consultancy relating to laboratory testing research; consulting services in the field of recombinant DNA technology research

Trademark Events
Sep 19, 2022
Final Disposition Notice Sent To Ib
Sep 19, 2022
Final Disposition Processed
Sep 7, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jun 7, 2022
Notice Of Registration Confirmation Emailed
Jun 7, 2022
Registered-Principal Register
Apr 29, 2022
Electronic Record Review Complete
Apr 1, 2022
On Hold - Electronic Record Review Required
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Feb 13, 2022
Notification Processed By Ib
Jan 26, 2022
Notification Of Possible Opposition Sent To Ib
Jan 26, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 11, 2022
Approved For Pub - Principal Register
Jan 8, 2022
Teas/Email Correspondence Entered
Jan 7, 2022
Correspondence Received In Law Office
Jan 7, 2022
Teas Response To Office Action Received
Sep 19, 2021
Notification Of Possible Opposition - Processed By Ib
Sep 1, 2021
Notification Of Possible Opposition Sent To Ib
Sep 1, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 7, 2021
Notification Of Non-Final Action E-Mailed
Jul 7, 2021
Non-Final Action E-Mailed
Jul 7, 2021
Non-Final Action Written
May 25, 2021
Limitation From The Ib - Request Exam Review
Feb 24, 2021
Notification Of Final Refusal Emailed
Feb 24, 2021
Final Refusal E-Mailed
Feb 24, 2021
Final Refusal Written
Jan 29, 2021
Teas/Email Correspondence Entered
Jan 29, 2021
Correspondence Received In Law Office
Jan 28, 2021
Assigned To Lie
Nov 27, 2020
Limitation Of Goods Received From Ib
Oct 19, 2020
Teas Response To Office Action Received
May 9, 2020
Refusal Processed By Ib
Apr 18, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Apr 18, 2020
Refusal Processed By Mpu
Apr 3, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Apr 3, 2020
Application Filing Receipt Mailed
Apr 2, 2020
Non-Final Action Written
Mar 30, 2020
Assigned To Examiner
Mar 30, 2020
New Application Office Supplied Data Entered In Tram
Mar 26, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24